Table of Content


1 INTRODUCTION 12
1.1 OBJECTIVES OF THE STUDY 12
1.2 MARKET DEFINITION 12
1.3 MARKET SCOPE 12
1.3.1 MARKETS COVERED 13
1.3.2 YEARS COVERED FOR THE STUDY 13
1.4 CURRENCY 14
1.5 LIMITATIONS 14
1.6 STAKEHOLDERS 14

2 RESEARCH METHODOLOGY 15
2.1 PRIMARY DATA 16
2.1.1 KEY DATA FROM PRIMARY SOURCES 16
2.2 SECONDARY DATA 17
2.2.1 KEY DATA FROM SECONDARY SOURCES 17
2.3 MARKET SIZE ESTIMATION 18
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 20
2.4.1 ASSUMPTIONS FOR THE STUDY 21

3 EXECUTIVE SUMMARY 22

4 PREMIUM INSIGHTS 25
4.1 OTC TESTS: MARKET OVERVIEW 25
4.2 OTC TESTS MARKET, BY TECHNOLOGY (2018–2024) 26
4.3 NORTH AMERICA: OTC TESTS MARKET, BY PRODUCT (2018) 27

5 MARKET OVERVIEW 28
5.1 INTRODUCTION 28
5.2 MARKET DYNAMICS 28
5.2.1 DRIVERS 29
5.2.1.1 Growing prevalence of diabetes 29
5.2.1.2 High prevalence of infectious diseases in developing countries 30
5.2.1.3 Growing support and collaboration for developing OTC tests 30
5.2.2 OPPORTUNITIES 31
5.2.2.1 Introduction of combined kits for testing pregnancy and ovulation 31
5.2.3 CHALLENGES 31
5.2.3.1 Invasiveness of blood glucose monitors and cholesterol monitors 31
?

6 OVER THE COUNTER TESTS MARKET, BY TECHNOLOGY 32
6.1 INTRODUCTION 33
6.2 LATERAL FLOW ASSAYS 33
6.2.1 LATERAL FLOW ASSAYS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 33
6.3 IMMUNOASSAYS 34
6.3.1 INCREASING USE OF IMMUNOASSAYS FOR PREGNANCY & INFECTIOUS DISEASE TESTING IS DRIVING MARKET GROWTH 34
6.4 DIPSTICKS 36
6.4.1 DIPSTICKS PROVIDE ONLY A QUALITATIVE ANALYSIS, WHICH IS A MAJOR FACTOR RESTRAINING MARKET GROWTH 36

7 OVER THE COUNTER TESTS MARKET, BY PRODUCT 38
7.1 INTRODUCTION 39
7.2 GLUCOSE MONITORING TESTS 39
7.2.1 GLUCOSE MONITORING TESTS DOMINATED THE OTC TESTS MARKET IN 2018 39
7.3 PREGNANCY & FERTILITY TESTS 41
7.3.1 ADVANTAGES OF PREGNANCY & FERTILITY TESTS HAVE DRIVEN COMPANIES TO FOCUS ON PRODUCT DEVELOPMENT 41
7.4 INFECTIOUS DISEASE TESTS 42
7.4.1 INCREASING PREVALENCE OF INFECTIOUS DISEASES IS DRIVING MARKET GROWTH 42
7.5 COAGULATION MONITORING TESTS 44
7.5.1 COAGULATION MONITORING TESTS PROVIDE QUICK AND RELIABLE RESULTS 44
7.6 URINALYSIS TESTS 45
7.6.1 INCREASING PREVALENCE OF URINARY TRACT INFECTIONS IS A MAJOR FACTOR DRIVING MARKET GROWTH 45
7.7 CHOLESTEROL TESTS 46
7.7.1 CONVENIENCE OF HOME-USE TESTS HAS EXPANDED THEIR USE 46
7.8 DRUGS-OF-ABUSE TESTS 48
7.8.1 RISING PRODUCTION AND CONSUMPTION OF ILLEGAL DRUGS HAVE DRIVEN THE FOCUS ON TESTING 48
7.9 OTHER TESTS 49

8 OVER THE COUNTER TESTS MARKET, BY REGION 51
8.1 INTRODUCTION 52
8.2 NORTH AMERICA 53
8.2.1 US 55
8.2.1.1 US to dominate the North America OTC tests market 55
8.2.2 CANADA 56
8.2.2.1 Increasing government initiatives to support the adoption of POC products to drive market growth in Canada 56
?
8.3 EUROPE 58
8.3.1 GERMANY 59
8.3.1.1 Germany is the fastest-growing market in Europe 59
8.3.2 FRANCE 61
8.3.2.1 High demand for glucose testing kits to drive market growth in France 61
8.3.3 UK 62
8.3.3.1 Increasing awareness of OCT tests among the users 62
8.3.4 REST OF EUROPE 63
8.4 ASIA PACIFIC 64
8.4.1 ASIA PACIFIC IS THE FASTEST-GROWING SEGMENT OF THE GLOBAL OTC TESTS MARKET 64
8.5 REST OF THE WORLD 67

9 COMPETITIVE LANDSCAPE 69
9.1 OVERVIEW 69
9.2 VENDOR BENCHMARKING 69
9.3 COMPETITIVE LEADERSHIP MAPPING 69
9.3.1 VISIONARY LEADERS 69
9.3.2 INNOVATORS 69
9.3.3 DYNAMIC DIFFERENTIATORS 69
9.3.4 EMERGING COMPANIES 69
9.4 MARKET RANKING ANALYSIS, 2017 71
9.5 COMPETITIVE SITUATION AND TRENDS 72
9.5.1 PRODUCT LAUNCHES 72
9.5.2 COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS 72
9.5.3 ACQUISITIONS 73
?

10 COMPANY PROFILES 74
(Business Overview, Products Offered, Recent Developments, MnM View)*
10.1 ROCHE DIAGNOSTICS 74
10.2 ABBOTT LABORATORIES 76
10.3 ORASURE TECHNOLOGIES 78
10.4 ACCUBIOTECH 80
10.5 LIA DIAGNOSTICS 81
10.6 LABSTYLE INNOVATIONS 82
10.7 SD BIOSENSOR 84
10.8 ACON LABORATORIES INC 85
10.9 SINOCARE 86
10.10 NOWDIAGNOSTICS COMPANY 88
10.11 I HEALTH LAB 89
10.12 BIOLYTICAL LABORATORIES 90
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

11 APPENDIX 91
11.1 DISCUSSION GUIDE 91
11.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 93
11.3 AVAILABLE CUSTOMIZATIONS 95
11.4 RELATED REPORTS 95
11.5 AUTHOR DETAILS 96



List of Figures



FIGURE 1 RESEARCH DESIGN 15
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 17
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 19
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 19
FIGURE 5 DATA TRIANGULATION 20
FIGURE 6 OTC TESTS MARKET, BY PRODUCT, 2018 VS. 2024 (USD MILLION) 22
FIGURE 7 OTC TESTS MARKET, BY TECHNOLOGY, 2018 VS. 2024 (USD MILLION) 23
FIGURE 8 GEOGRAPHICAL SNAPSHOT OF THE OTC TESTS MARKET 24
FIGURE 9 RISING PREVALENCE OF TARGET DISEASES AND DISORDERS IS A KEY DRIVER FOR THE OTC TESTS MARKET 25
FIGURE 10 LATERAL FLOW ASSAYS TO CONTINUE TO DOMINATE THE OTC TESTS
MARKET IN 2024 26
FIGURE 11 GLUCOSE MONITORING TESTS ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN OTC TESTS MARKET IN 2018 27
FIGURE 12 OTC TESTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 28
FIGURE 13 NORTH AMERICA: OTC TESTS MARKET SNAPSHOT 53
FIGURE 14 APAC: OTC TESTS MARKET SNAPSHOT 65
FIGURE 15 OTC TESTS MARKET (GLOBAL), COMPETITIVE LEADERSHIP MAPPING, 2017 70
FIGURE 16 RANK OF COMPANIES IN THE GLOBAL OTC TESTS MARKET, 2017 71
FIGURE 17 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2018) 74
FIGURE 18 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2018) 76
FIGURE 19 ORASURE TECHNOLOGIES: COMPANY SNAPSHOT (2017) 78
FIGURE 20 LABSTYLE INNOVATIONS: COMPANY SNAPSHOT (2017) 82

 

List of Tables



TABLE 1 TOP 10 COUNTRIES WITH THE HIGHEST NUMBER OF DIABETICS
(20–79 YEARS), 2017 VS. 2045 (MILLION) 29
TABLE 2 OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION) 33
TABLE 3 OTC TESTS MARKET FOR LATERAL FLOW ASSAYS, BY REGION 2016–2024 (USD MILLION) 33
TABLE 4 NORTH AMERICA: OTC TESTS MARKET FOR LATERAL FLOW ASSAYS BY COUNTRY, 2016–2024 (USD MILLION) 34
TABLE 5 EUROPE: OTC TESTS MARKET FOR LATERAL FLOW ASSAYS, BY COUNTRY 2016–2024 (USD MILLION) 34
TABLE 6 OTC TESTS MARKET FOR IMMUNOASSAYS, BY REGION 2016–2024 (USD MILLION) 35
TABLE 7 NORTH AMERICA: OTC TESTS MARKET FOR IMMUNOASSAYS, BY COUNTRY 2016–2024 (USD MILLION) 35
TABLE 8 EUROPE: OTC TESTS MARKET FOR IMMUNOASSAYS, BY COUNTRY 2016–2024 (USD MILLION) 35
TABLE 9 OTC TESTS MARKET FOR DIPSTICKS, BY REGION, 2016–2024 (USD MILLION) 36
TABLE 10 NORTH AMERICA: OTC TESTS MARKET FOR DIPSTICKS, BY COUNTRY 2016–2024 (USD MILLION) 36
TABLE 11 EUROPE: OTC TESTS MARKET FOR DIPSTICKS, BY COUNTRY 2016–2024 (USD MILLION) 37
TABLE 12 OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION) 39
TABLE 13 OTC GLUCOSE MONITORING TESTS MARKET, BY REGION 2016–2024 (USD MILLION) 40
TABLE 14 NORTH AMERICA: OTC GLUCOSE MONITORING TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION) 40
TABLE 15 EUROPE: OTC GLUCOSE MONITORING TESTS MARKET, BY COUNTRY 2016–2024 (USD MILLION) 40
TABLE 16 OTC PREGNANCY & FERTILITY TESTS MARKET, BY REGION 2016–2024 (USD MILLION) 41
TABLE 17 NORTH AMERICA: OTC PREGNANCY & FERTILITY TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION) 41
TABLE 18 EUROPE: OTC PREGNANCY & FERTILITY TESTS MARKET, BY COUNTRY 2016–2024 (USD MILLION) 42
TABLE 19 OTC INFECTIOUS DISEASE TESTS MARKET, BY REGION 2016–2024 (USD MILLION) 42
TABLE 20 NORTH AMERICA: OTC INFECTIOUS DISEASE TESTS MARKET, BY COUNTRY 2016–2024 (USD MILLION) 43
TABLE 21 EUROPE: OTC INFECTIOUS DISEASE TESTS MARKET, BY COUNTRY 2016–2024 (USD MILLION) 43
TABLE 22 OTC COAGULATION MONITORING TESTS MARKET, BY REGION 2016–2024 (USD MILLION) 44
TABLE 23 NORTH AMERICA: OTC COAGULATION MONITORING TESTS MARKET BY COUNTRY, 2016–2024 (USD MILLION) 44
TABLE 24 EUROPE: OTC COAGULATION MONITORING TESTS MARKET, BY COUNTRY 2016–2024 (USD MILLION) 45
TABLE 25 OTC URINALYSIS TESTS MARKET, BY REGION, 2016–2024 (USD MILLION) 45
TABLE 26 NORTH AMERICA: OTC URINALYSIS TESTS MARKET, BY COUNTRY 2016–2024 (USD MILLION) 46
TABLE 27 EUROPE: OTC URINALYSIS TESTS MARKET, BY COUNTRY 2016–2024 (USD MILLION) 46
TABLE 28 OTC CHOLESTEROL TESTS MARKET, BY REGION, 2016–2024 (USD MILLION) 47
TABLE 29 NORTH AMERICA: OTC CHOLESTEROL TESTS MARKET, BY COUNTRY 2016–2024 (USD MILLION) 47
TABLE 30 EUROPE: OTC CHOLESTEROL TESTS MARKET, BY COUNTRY 2016–2024 (USD MILLION) 47
TABLE 31 OTC DRUGS-OF-ABUSE TESTS MARKET, BY REGION, 2016–2024 (USD MILLION) 48
TABLE 32 NORTH AMERICA: OTC DRUGS-OF-ABUSE TESTS MARKET, BY COUNTRY 2016–2024 (USD MILLION) 48
TABLE 33 EUROPE: OTC DRUGS-OF-ABUSE TESTS MARKET, BY COUNTRY 2016–2024 (USD MILLION) 49
TABLE 34 OTC OTHER TESTS MARKET, BY REGION, 2016–2024 (USD MILLION) 49
TABLE 35 NORTH AMERICA: OTC OTHER TESTS MARKET, BY COUNTRY 2016–2024 (USD MILLION) 50
TABLE 36 EUROPE: OTC OTHER TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION) 50
TABLE 37 OTC TESTS MARKET, BY REGION, 2016–2024 (USD MILLION) 52
TABLE 38 NORTH AMERICA: OTC TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION) 54
TABLE 39 NORTH AMERICA: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION) 54
TABLE 40 NORTH AMERICA: OTC TESTS MARKET, BY TECHNOLOGY 2016–2024 (USD MILLION) 54
TABLE 41 US: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION) 56
TABLE 42 US: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION) 56
TABLE 43 CANADA: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION) 57
TABLE 44 CANADA: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION) 58
TABLE 45 EUROPE: OTC TESTS MARKET, BY COUNTRY, 2016–2024 (USD MILLION) 58
TABLE 46 EUROPE: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION) 59
TABLE 47 EUROPE: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION) 59
TABLE 48 GERMANY: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION) 60
TABLE 49 GERMANY: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION) 60
TABLE 50 FRANCE: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION) 61
TABLE 51 FRANCE: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION) 62
TABLE 52 UK: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION) 62
TABLE 53 UK: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION) 63
TABLE 54 ROE: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION) 63
TABLE 55 ROE: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION) 64
TABLE 56 APAC: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION) 66
TABLE 57 APAC: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION) 66
TABLE 58 ROW: OTC TESTS MARKET, BY PRODUCT, 2016–2024 (USD MILLION) 67
TABLE 59 ROW: OTC TESTS MARKET, BY TECHNOLOGY, 2016–2024 (USD MILLION) 68
TABLE 60 PRODUCT LAUNCHES, 2016–2019 72
TABLE 61 COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS, 2016–2019 72
TABLE 62 ACQUISITIONS, 2016-2019 73